Sandoz Group AG (XSWX:SDZ) Accumulated Depreciation: CHF0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:SDZ Sandoz Group AG XSWX:SDZ
27 GF Score
Price CHF73.00
GF Value CHF46.76
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Sandoz Group AG Accumulated Depreciation?

Sandoz Group AG XSWX:SDZ -0.98% 27 Accumulated Depreciation is CHF0 Mil as of Jun. 2026. GuruFocus rates XSWX:SDZ with a GF Score™ of 27/100 and a GF Value™ of CHF46.76 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Sandoz Group AG's quarterly accumulated depreciation increased from Jun. 2025 (CHF0 Mil) to Dec. 2025 (CHF-2,115 Mil) but then stayed the same from Dec. 2025 (CHF-2,115 Mil) to Jun. 2026 (CHF0 Mil).

Sandoz Group AG's annual accumulated depreciation declined from Dec. 2023 (CHF-2,114 Mil) to Dec. 2024 (CHF-2,014 Mil) but then increased from Dec. 2024 (CHF-2,014 Mil) to Dec. 2025 (CHF-2,115 Mil).


Sandoz Group AG Accumulated Depreciation Related Terms


Sandoz Group AG Accumulated Depreciation Historical Data

* Premium members only.

The historical data trend for Sandoz Group AG's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sandoz Group AG Accumulated Depreciation Chart

Sandoz Group AG Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Accumulated Depreciation
-2,958.76 -2,114.44 -2,014.12 -2,114.97

Sandoz Group AG Semi-Annual Data
Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Accumulated Depreciation Get a 7-Day Free Trial 0.00 -2,014.12 0.00 -2,114.97 0.00
XSWX:SDZ
27GF Score
Sandoz Group AG XSWX:SDZ
Accumulated Depreciation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sandoz Group AG Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

What does a Accumulated Depreciation of CHF0 Mil mean?
Sandoz Group AG (XSWX:SDZ) has a Accumulated Depreciation of CHF0 Mil as of Jun. 2026. Accumulated depreciation is a contra-asset item that accounts for the decline in value of long-term assets. View historical data on Sandoz Group AG and its competitors.
Is Sandoz Group AG's Accumulated Depreciation too high?
Sandoz Group AG's current Accumulated Depreciation is CHF0 Mil. Overall, Sandoz Group AG has a GF Score™ of 27/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Sandoz Group AG's Accumulated Depreciation compare to ZTS and UTHR?
Sandoz Group AG's Accumulated Depreciation of CHF0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accumulated Depreciation for a Drug Manufacturers company?
A good Accumulated Depreciation depends on the Drug Manufacturers industry context. However, Accumulated Depreciation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accumulated Depreciation mean?
A high Accumulated Depreciation can signal that a stock is expensive relative to its fundamentals. Accumulated depreciation is a contra-asset item that accounts for the decline in value of long-term assets. View historical data on Sandoz Group AG and its competitors. Sandoz Group AG's current Accumulated Depreciation is CHF0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sandoz Group AG stock overvalued right now?
Based on GuruFocus' analysis, Sandoz Group AG (XSWX:SDZ) is currently considered Significantly Overvalued. The stock's GF Value™ is CHF46.76, compared to a current price of CHF73.00 — trading 56.1% above its estimated fair value. The current Accumulated Depreciation is CHF0 Mil. Sandoz Group AG's overall GF Score™ is 27/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accumulated Depreciation calculated?
Accumulated Depreciation is calculated from a company's financial statements. For Sandoz Group AG (XSWX:SDZ), the current Accumulated Depreciation is CHF0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sandoz Group AG (XSWX:SDZ) Overvalued in 2026?

Based on GuruFocus' analysis, Sandoz Group AG stock appears to be overvalued. The current stock price of CHF73.00 is trading 56.1% above its estimated GF Value™ of CHF46.76. GuruFocus considers Sandoz Group AG to be Significantly Overvalued.

Key valuation signals for XSWX:SDZ:

  • Accumulated Depreciation: CHF0 Mil
  • GF Value™: CHF46.76 vs. price of CHF73.00 (56.1% above fair value)
  • GF Score™: 27/100 with 6 warning signs

No single metric tells the full story. See the XSWX:SDZ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sandoz Group AG Business Description

Address Centralbahnstrasse 4, Basel, CHE, 4051
Sandoz is one of the largest generic pharmaceutical manufacturers in the world, generating over $11 billion annually from off-patent drugs. Once part of Novartis, Sandoz spun off and went public in October 2023. Generics, including small molecules and complex injectables, make up roughly 75% of Sandoz's total sales, and the firm has a significant presence in Europe, the United States, and other key international markets. Sandoz generates its remaining sales from biosimilars and is among the leaders in the space. Sandoz launched Europe's first biosimilar, Omnitrope, in 2006, as well as the first US biosimilar, Zarxio, in 2015. It has over 10 launched biosimilars in a number of markets and over 20 assets in its pipeline.
27GF Score

Get the complete analysis for XSWX:SDZ

Accumulated Depreciation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF73.00
Price
CHF46.76
GF Value